Therapeutic effect and security of triple antiplatelet with Cilostazol in the elderly after drug-eluting stent implantation
10.3760/cma.j.issn.0254-9026.2012.03.003
- VernacularTitle:老年人药物洗脱支架置入术后应用西洛他唑的疗效和安全性
- Author:
Rui TIAN
;
Shuzheng LV
;
Hong LIU
;
Fei YUAN
;
Xin CHEN
;
Huagang ZHU
;
Xiantao SONG
;
Yuan ZHOU
;
Changjiang GE
- Publication Type:Journal Article
- Keywords:
Drug-eluting stent;
Blood platelet;
Coronary artery disease
- From:
Chinese Journal of Geriatrics
2012;31(3):185-188
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the therapeutic effect and security of triple antiplatelet with cilostazol in the elderly after drug-eluting stent implantation and compare it with double antiplatelet treatment. Methods 234 elderly patients with coronary disease were randomly divided into two groups.118 cases in the triple antiplatelet group were treated with clopidogrel (300 or 600 mg/d) and aspirin(100 mg/d) in addition with cilostazol(200mg/d) from pre surgery to 6 month after surgery,then received double antiplatelet treatment.116 cases in the double antiplatelet group were treated with Aspirin(100 mg/d) and clopidogrel(300 or 600 mg/d),then clopidogrel was ceased after 1 year and used only Aspirin. The main parameters during follow up included all-cause death,major adverse cardiovascular events (MACE) and major adverse cardiac and cerebrovascular event (MACCE),the secondary parameters during follow- up were recurrence of angina pectoris,myocardial infarction,revascularization and hemorrhage within 2 years. Results The recurrence of angina pectoris and revascularization were found in 1 case (0.85％) and 1 case(0.85％) respectively in the triple antiplatelet group,while 8 cases(6.90％) and 8 cases (6.90％) in the double antiplatelet group,with significant difference between the two groups(both x2 =4.27,P＜0.05).All cause death,myocardial infarction,cerebral apoplexy and hemorrhage were not found in the triple antiplatelet group,while 1 case of death,1 case with myocardial infarction,1 case with apoplexy and no hemorrhage appeared in the double antiplatelet group,with no significant difference between the two groups(P＞0.05).Conclusions The triple antiplatelet added with cilostazol in the elderly after drug eluting stent implantation may decrease the recurrence of angina pectoris and revascularization with higher security.
